WÄDENSWIL, Switzerland–Countering prior theories soy isoflavone supplementation can contribute to increased breast cancer risk, new findings from the Osteoporosis Prevention Using Soy (OPUS) intervention study, funded by the USDA, has confirmed that long-term supplementation with soy hypocotyl isoflavones does not cause adverse effects. The findings wee published in the American Journal of Clinical Nutrition (2011; […]
Author Archive | ronny
Long-term clinical study delivers convincing results on the safety of soy hypocotyl isoflavones in menopausal women. Wädenswil/Switzerland, February 2011 The Osteoporosis Prevention Using Soy (OPUS) intervention study, funded by the United States Department of Agriculture (USDA), has confirmed that regular supplementation with soy hypocotyl isoflavones over long periods does not cause adverse effects. It can […]
soy is not only believed to provide relief from postmenopausal symptoms such as hot flushes
Abstract: A long-term study shows that soy isoflavones hypocotyl for women in the Menopause are safe. Frutarom is relieved. Title: alimentaonline.ch Issue: 11 February 2011 Country: United States Page: online publication Circulation: On behalf of the U.S. Department of Agriculture (USDA) conducting the OPUS (Osteoporosis Prevention Using Soy) intervention study, results showed that regular intake […]
Products derived from soy bean are produced from defatted soy meal (rest of soy oil production). During this process are harsh solvents needed like hexane. Removal of many beneficial phytonutrients -> isolation/ extraction of single nutrients. SoyLife® is produced from whole soy germ without using any harsh solvents. After roasting the whole germ and only […]
No, SoyLife® EXTRA is direct compressible.
Yes. None of our SoyLife products are water soluble and stabilizers are required.
Yes in dry and liquid forms.
The roasting process is the base of our manufacturing process. It extends the shelf life, improves digestion and the flavour profile. We do not use hexane during our extraction.